[Exogenous lipoid pneumonia]

P Garzón Lorenzo1, A Torrent Vernetta, L Server Salvà

  • 1Unidad de Neumología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, España. paula_garzon@hotmail.com

Insights

Accidental ingestion of lipid formulations can cause exogenous lipoid pneumonia in children. Suspect this condition in pediatric patients with respiratory symptoms and a history of lipid substance intake and vomiting.

Area of Science:

  • Pediatric Pulmonology
  • Radiology
  • Toxicology

Background:

  • Exogenous lipoid pneumonia in children is frequently caused by the aspiration of lipid substances.
  • Accidental ingestion of lipid formulations is a common route for this aspiration.

Observation:

  • Clinical presentation can vary, including cough, dyspnea, and chest pain.
  • Radiographic findings often show alveolar infiltrates.
  • A history of lipid substance ingestion and vomiting is a key indicator.

Findings:

  • Two pediatric cases of aspiration lipoid pneumonia are presented.
  • One case demonstrated the development of pneumatoceles secondary to aspiration.
  • Clinical and radiological outcomes differed between the two cases.

Implications:

  • Highlights the importance of considering aspiration lipoid pneumonia in pediatric respiratory distress.
  • Emphasizes the diagnostic role of clinical history and chest imaging.
  • Illustrates potential complications such as pneumatoceles in aspiration lipoid pneumonia.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: